MSB 2.11% 97.0¢ mesoblast limited

Cell Therapy News/Articles, page-17002

  1. 15,521 Posts.
    lightbulb Created with Sketch. 5593
    Still plenty of government funding around for COVID-19 therapeutics ….. Remestemcel-L is a therapeutic treatment for COVID-19 ARDS so perhaps Jane Bell should make some enquiries ?



    https://www.hhs.gov/about/news/2023...dvance-development-vaccines-therapeutics.html

    Project NextGen Selects Initial Vaccine Candidates and Awards Over $500 Million to Advance Development of Vaccines and Therapeutics


    Today, the U.S. Department of Health and Human Services (HHS), through the Administration for Strategic Preparedness and Response (ASPR), is announcing the selection of initial next-generation vaccine candidates and more than $500 million in awards for Project NextGen – kick-starting planning for Phase 2b clinical trials and technologies that advance innovative next-generation vaccine and therapeutics platforms.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.020(2.11%)
Mkt cap ! $1.107B
Open High Low Value Volume
94.5¢ 98.0¢ 93.5¢ $3.680M 3.810M

Buyers (Bids)

No. Vol. Price($)
5 149921 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 60000 1
View Market Depth
Last trade - 16.10pm 12/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.